Germany-based natural cosmetics company Evertz Pharma GmbH has become the first German company to adopt the strategic Bitcoin reserve model.
The company expanded its treasury reserves by purchasing 100 Bitcoins worth approximately 10 million euros (about $10.8 million) in May 2025.
Evertz Pharma’s interest in Bitcoin is not new. The company began accumulating BTC in December 2020 with its first purchase of €2 million, and has since been building a digital reserve by regularly allocating a portion of its profits to Bitcoin.
The company’s General Manager, Dominik Evertz, said in a statement on the subject: “In line with our mission to promote science-based natural beauty, we act with a forward-looking mindset. With its rarity and global tradability, BTC complements our reserve strategy and strengthens our company’s long-term resilience.”
With the latest purchase of 100 BTC, Evertz Pharma stands out from its competitors in the sector and traditional treasury management practices. “We will continue to purchase Bitcoin with our company profits and are constantly evaluating new ways to sustainably increase our assets,” said Group CFO Tobias Evertz.
Unlike BTC investors like Strategy or Metaplanet, which are publicly traded companies, Evertz Pharma operates as a private German company.
Dominik Evertz argued that Bitcoin is not just an investment vehicle, but also a strategic asset that complements the company’s vision of stability and sustainability. He noted that Bitcoin also offers a hedge against inflation and capital preservation without the storage difficulties of traditional assets like gold.
*This is not investment advice.